Rothwell Formulations Private Limited
About Rothwell Formulations Private Limited
Data last updated:
Rothwell Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 15 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2015PTC264492. Its GSTIN is 27AAHCR3830R1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rekha Singh and Abhijeet Narinderpal Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.57 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net loss of ₹18,122 (net margin -4%) and EBITDA of -₹18,122 (EBITDA margin -4%). Revenue has declined at a compounded annual rate (CAGR) of 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No 6 Cts No. 658 – A 658 – B Gayatri Bhuvan Thakur Complex 90 Feet Road Opp. Munci, Pal Ground, Mumbai, Maharashtra, India – 400101
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rothwell Formulations Private Limited
The main business activity of Rothwell Formulations is manufacturing. In detail, this covers other manufacturing.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 32 | Other manufacturing | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rothwell Formulations Private Limited FY 2025 filings available
Rothwell Formulations Private Limited reported revenue of ₹4.57 Lakh (up 44% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rothwell Formulations Private Limited
Revenue rose 44% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rothwell Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹18,122 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹18,122 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rothwell Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rothwell Formulations are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Rothwell Formulations Private Limited
Rothwell Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Singh | Director | 15 May 2015 | 11 Years 5 Months | Current |
| Abhijeet Narinderpal Singh | Director | 15 May 2015 | 11 Years 5 Months | Current |
Peer Comparison of Rothwell Formulations Private Limited
Rothwell Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shanti Medi Treat Pvt Ltd | ₹4.64 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Howrah, West Bengal, India |
| Daisy Formulations Private Limited | ₹4.59 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Narsinghpur, Madhya Pradesh, India |
| Karpagam Laboratories Private Limited | ₹4.58 Lakh (FY 2025) | •••• | •••• | 1892.0% | •••• | Coimbatore, Tamil Nadu, India |
| Rechem Pharma Private Limited | ₹4.58 Lakh (FY 2024) | •••• | •••• | -23.0% | •••• | Mannarkkad, Kerala, India |
| Valleysun Pharma Private Limited | ₹4.58 Lakh (FY 2021) | •••• | •••• | •••• | Kalyan West, Maharashtra, India | |
| Rothwell Formulations Private Limited this company | ₹4.57 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Mumbai, Maharashtra, India |
| RSND Formulations (OPC) Private Limited | ₹4.55 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Mithoni, Uttar Pradesh, India |
| Biored Remedies Private Limited | ₹4.55 Lakh (FY 2025) | •••• | •••• | 98.0% | •••• | Krishnarajapuramhobli, Karnataka, India |
| VL Pharmaceuticals Private Limited | ₹4.52 Lakh (FY 2019) | •••• | •••• | 133.0% | •••• | Lucknow, Uttar Pradesh, India |
| Primd Pharma Private Limited | ₹4.51 Lakh (FY 2024) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
| Boots Healthcare Private Limited | ₹4.49 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Rothwell Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rothwell Formulations Private Limited
Rothwell Formulations Private Limited is audited by SANADHYA MANDOT & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SANADHYA MANDOT & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rothwell Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rothwell Formulations Private Limited
Rothwell Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Rothwell Formulations Private Limited
Employment history and EPFO contributions of people linked to Rothwell Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rothwell Formulations Private Limited
Rothwell Formulations Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Abhijeet Narinderpal Singh was appointed as Director on 15 May 2015.
Credit Ratings, Litigation & Regulatory Alerts for Rothwell Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rothwell Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rothwell Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rothwell Formulations Private Limited
Rothwell Formulations has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR3830R1ZR | Maharashtra | Active | 26 Jul 2017 |
| 04AAHCR3830R1ZZ | Chandigarh | Active | 04 Dec 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rothwell Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rothwell Formulations Private Limited
Rothwell Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 15 May 2015 (11+ years old) and is registered under CIN U51909MH2015PTC264492.
Rothwell Formulations reported revenue of ₹4.57 Lakh for FY 2025 (up 44% YoY).
Rothwell Formulations has 2 current directors:
- Rekha Singh - Director
- Abhijeet Narinderpal Singh - Director
Rothwell Formulations reported a net loss of ₹18,122 (net margin -4%) and EBITDA of -₹18,122 (EBITDA margin -4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rothwell Formulations is -13% over five years. In the latest year (FY 2025) revenue rose 44%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rothwell Formulations is 27AAHCR3830R1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 04AAHCR3830R1ZZ (Chandigarh).
The CIN (Corporate Identification Number) of Rothwell Formulations is U51909MH2015PTC264492. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rothwell Formulations was incorporated on 15 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rothwell Formulations by revenue are Shanti Medi Treat Pvt Ltd, Daisy Formulations Private Limited, Karpagam Laboratories Private Limited, Rechem Pharma Private Limited, Valleysun Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Abhijeet Narinderpal Singh was appointed as Director on 15 May 2015. Rekha Singh was appointed as Director on 15 May 2015.
The registered office of Rothwell Formulations is at Office No 6 Cts No. 658 – A 658 – B Gayatri Bhuvan Thakur Complex 90 Feet Road Opp. Munci, Pal Ground, Mumbai, Maharashtra, India – 400101.